Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan
· Delayed Price · Currency is TWD 151.00
-4.50 (-2.89%)
Feb 21, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 10.09 billion as of February 21, 2025. Its market cap has decreased by -14.51% in one year.
Market Cap
10.09B
Enterprise Value
7.66B
Revenue
474.29M
Ranking
n/a
PE Ratio
24.03
Stock Price
151.00
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 10.09B, an increase of 293.25%. That is a compound annual growth rate of 36.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 10.09B | 6.71% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 213.05B |
| Caliway Biopharmaceuticals | 143.06B |
| Bora Pharmaceuticals Co., LTD. | 90.22B |
| Lotus Pharmaceutical | 72.97B |
| Lumosa Therapeutics | 39.69B |
| Oneness Biotech | 38.96B |
| Polaris Group | 34.55B |
| Pegavision | 30.65B |